Skip to main content
See every side of every news story
Published loading...Updated

Ozempic and Wegovy may have an unexpected mental health benefit

Summary by Science Daily
Semaglutide, the drug behind Ozempic and Wegovy, may have benefits that extend well beyond weight loss and diabetes. In a large Swedish study of nearly 15,000 people with bipolar disorder, its use was linked to a 21% lower risk of psychiatric hospitalization. Researchers think effects on inflammation and brain-related biological pathways could help stabilize mood, though other GLP-1 drugs did not show the same association.

4 Articles

JPNN.com, JAKARTA - A study involving researchers from Griffith University, Australia, found that the use of semaglutide is associated with a reduced risk of psychiatric hospitalization in people with bipolar disorder.

·Indonesia
Read Full Article

A new, large-scale study from Sweden brings to light a possible, unexpected relationship between semaglutide and the course of bipolar disorder...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Science Daily broke the news in Encinitas, United States on Tuesday, September 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal